Sonoma Pharmaceuticals Faces Stock Decline After Pricing Public Offering
Sonoma Pharmaceuticals, a prominent global healthcare leader specializing in the development and production of patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products across various applications,
